Anne's Place IV

COMPLAINT INVESTIGATION REPORT

The facility underwent an unannounced annual inspection on July 25, 2024. The inspector noted that the facility maintained best practices across Infection Control and Physical Plant areas. Crucially, the report explicitly states that no deficiencies were cited during the inspection.

The facility underwent an unannounced annual inspection and was found to have two deficiencies related to medication management. Specifically, deficiencies were noted regarding the storage of medications in original containers and the presence of PRN medications not documented on the MAR. Both deficiencies are classified as Type B, requiring corrective action by July 28, 2023.

The facility underwent an unannounced annual inspection. The Licensing Program Analyst observed sufficient infection control measures, including adequate hand hygiene supplies, cleaning provisions, and proper use of PPE. No deficiencies were observed during the visit.

The facility underwent an unannounced annual required licensing inspection. The inspector noted that the facility is in compliance with and has implemented infection control practices as outlined in its LIC 808 plan. No deficiencies were observed during the visit.